Deep Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Deep Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: The Incidence of Perioperative Deep Venous Thromboses of the Lower Extremities [NA]
Completed clinical trial from the University of Illinois at Chicago assessing the incidence of perioperative deep vein thrombosis in the low…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Mechanical Thrombectomy and Catheter Directed Thrombolysis Utilization in Patients With Deep Vein Thrombosis
A completed clinical trial update examining the use of mechanical thrombectomy and catheter-directed thrombolysis in patients with deep vein…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome [Phase 4]
Phase 4 trial update on tinzaparin lead-in to prevent post-thrombotic syndrome in patients with deep vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) [Phase 4]
Phase 4 clinical trial comparing Lovenox 30 mg twice daily versus 40 mg once daily in trauma/surgery patients, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Compression Hosiery to Avoid Post-Thrombotic Syndrome [NA]
A terminated clinical trial investigated compression hosiery to prevent post-thrombotic syndrome in patients with deep vein thrombosis; resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis [Phase 3]
A Phase 3 clinical trial update reports eight-week treatment with a venoactive drug for deep vein thrombosis, focusing on resolution enhance…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma [Phase 2]
Phase 2 clinical trial evaluating weight-based enoxaparin dosing with real-time dose adjustment for orthopaedic trauma; study completed with…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy [Phase 3]
A Phase 3 trial evaluated apixaban to prevent recurrent cancer-related venous thromboembolism in patients who completed initial anticoagulat…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: OsciPulse Device for the Prevention of VTE [NA]
Completed clinical trial of the OsciPulse device for prevention of venous thromboembolism with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study [Phase 1]
Phase 1 pediatric PK/PD study completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer [NA]
A completed clinical trial comparing direct oral anticoagulants (DOACs) to LMWH with or without warfarin for venous thromboembolism in cance…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis [Phase 4]
Phase 4 clinical trial update for apixaban in routine management of upper extremity deep venous thrombosis; study status terminated.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT) [Phase 2]
Phase 2 trial of BAY59-7939 (oral direct Factor Xa inhibitor) in acute symptomatic proximal deep vein thrombosis has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 [Phase 4]
Phase 4 trial comparing weight-adjusted versus fixed low-dose low molecular weight heparin for venous thromboembolism prevention in COVID-19…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis [Phase 4]
Clinical trial update on recombinant hirudin for prophylaxis of postoperative deep vein thrombosis (Phase 4).
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) [Phase 3]
A Phase 3 pediatric trial evaluating edoxaban for confirmed venous thromboembolism has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis [NA]
Clinical trial evaluating preventive dosing of fondaparinux vs placebo for preventing venous thromboembolism in patients undergoing coronary…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. [Phase 3]
Phase 3 trial updating on the prevention of recurrent thrombosis with Xarelto compared to no treatment in patients with chronic portal vein …
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 [Phase 3]
Phase 3 trial of enoxaparin for primary thromboprophylaxis in ambulatory COVID-19 patients was terminated.
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Screening for Cancer in Patients With Unprovoked VTE [Phase 4]
Phase 4 trial update focused on screening for cancer in patients with unprovoked venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis [Phase 1, Phase 2]
Early-phase clinical trial update on mechanisms of deep vein thrombosis and vein wall fibrosis in conditions including post-thrombotic syndr…
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis [Phase 3]
Phase 3 trial update for apixaban in treating calf vein thrombosis (a form of deep vein thrombosis).
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT) [NA]
Clinical trial update for the PACT study assessing physical activity in children at risk of post-thrombotic sequelae, with completed status …
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism [Phase 4]
Phase 4 clinical trial updating D-dimer guidance to establish duration of anticoagulation after venous thromboembolism has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis [Phase 3]
Phase 3 trial update evaluating the efficacy of apixaban in patients with malignancy-associated deep vein thrombosis.